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Potential mechanisms of action
Epilepsy
Alzheimer disease / cognitive impairment Decreased beta amyloid deposition
Parkinson's disease Enhanced mitochondrial function
Amyotrophic lateral sclerosis Enhanced mitochondrial function
Traumatic brain injury Ketone body utilization, enhanced mitochondrial function
Hypoxic / ischemic brain injury Ketone body utilization, enhanced mitochondrial function
Autism Enhanced mitochondrial function
Depression Enhanced mitochondrial function
Migraine Enhanced mitochondrial function
Narcolepsy Enhanced mitochondrial function
Cancers expressing the Warburg effect Ketone body utilization, enhanced mitochondrial function
GLUT-1 deficiency2 Ketone body utilization
PDH deficiency3 Ketone body utilization
PFK deficiency4 Ketone body utilization
McArdle disease (Glycogenosis type V) Ketone body utilization
Cardiac ischemia Ketone body utilization, enhanced mitochondrial function
1Modified from Baranano & Hartman. (2008). Current treatment options in neurology. 10(6), 410-419.





Enhanced mitochondrial function; fatty acid effect on ion channels, 
neurotransmission and neurotransmitters; decreased effects from reactive 
oxygen species; reduced glucose utilization
Metabolic
Other
Table 1. Potential uses of dietary therapy in various illnesses (clinical and laboratory studies)1
! 14!
!!!!!!!!!!!!!!!!!
0.3 - 0.5 12-24 hrs 3 - 5%
1.5 2-3 days 18%
5 8 days 60%
7 - 8 ≥ 20 days > 60%
1Modified from Hashim & VanItallie. (2014). Journal of Lipid Research . 55(9), 1818-1826.
Plasma KB 
concentration (mM)
Fasting time to achieve 
plasma KB concentrations
Proportion of brain 
energy metabolism
Table 2. Proportion of brain energy metabolism supported by ketone bodies, 
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Conflicting results on blood lipid and glucose levels were reported in humans and 
mice on the ketogenic diet.  In adults on the ketogenic diet, triglyceride levels remain 
unchanged or are lowered, whereas cholesterol levels remain unchanged, are lowered, or 
are increased (Dashti et al., 2006; Klement et al., 2013; Westman et al., 2002; Yancy et 
al., 2004). The ketogenic diet increases plasma triglyceride and cholesterol levels in 
children (Kwiterovich et al., 2003).  Fasting glucose in both adults and children remains 
unchanged or is lowered on the ketogenic diet (Brehm et al., 2003; De Vivo, 1983; 
Klement et al., 2013; Meckling et al., 2004; Tendler et al., 2007; Volek et al., 2003), 
whereas the blood ketones are consistently increased (Gilbert et al., 2000).  In mice, the 
ketogenic diet decreases plasma triglyceride levels while increasing cholesterol levels 
(Badman et al., 2009; Kennedy et al., 2007).  Increased, decreased, or no change in 
plasma glucose levels were reported in mice on the ketogenic diet (Kennedy et al., 2007; 
Mantis et al., 2004; Seyfried et al., 2003).  As in children, plasma ketone levels are 
! 44!



























































































































Standard Diet Ketogenic Dieta Fish-Oil Dietb








Table 3. Composition (%) of Standard Diet, Ketogenic Diet, and Fish-Oil supplemented Diet
b 1g of fish oil capsule per 3g of SD; each gram contains 180 mg EPA and 120 mg DHA
























Table 4.  Influence of dietary intake on body weight and calorie consumption in C57BL/6J mice
UR R UR R UR R
Final Bodyweight (g)a 29.0 ± 0.7 23.6 ± 0.1 32.5 ± 0.7 23.3 ± 0.3 27.9 ± 0.9 23.1 ± 0.2
Bodyweight Change (%) +0.3 ± 1.8 -21.1 ± 1.4 +11.2 ± 2.3 -19.9 ± 0.6 -10.7 ± 2.7 -22.4 ± 1.1
Engergy Intake (kcal)b 15.0 ± 0.4 11.3 ± 0.6 13.4 ± 0.3 10.1 ± 0.3 13.1 ± 0.6 10.2 ± 0.2
Calorie Difference (%)c 0.0 ± 1.3 -24.4 ± 1.1 0.0 ± 1.2 -24.9 ± 2.2 0.0 ± 4.6 -22.3 ± 1.9
     from UR Diet
Calorie Difference (%)d 0.0 ± 1.3 -24.4 ± 1.1 -10.5 ± 1.1 -32.8 ± 1.9 -12.2 ± 4.0 -31.8 ± 1.7
     from SD-UR
a Values are expressed as the mean ± SEM (n = 4 mice per group)
b Mean metabolizable energy (kcal) consumed per mouse per day from days 7-31
Diet
c From UR diet




UR R UR R UR R
Metabolitesa
Glucose (mM) 12.8 ± 0.5 6.1 ± 0.4* 15.1 ± 0.4§ 8.5 ± 0.5*§ 8.7 ± 0.6§ 6.0 ± 0.1*§
β-Hydroxybutyrate (mM) 0.4 ± 0.0 1.4 ± 0.2* 1.1 ± 0.1§ 2.9 ± 0.2*§ 0.9 ± 0.1§ 2.0 ± 0.1*§
Glucose/β-Hydroxybutyrate 35.4 ± 4.7 4.6 ± 1.0* 13.4 ± 2.5§ 2.9 ± 0.9*§ 10.4 ± 2.2§ 3.0 ± 0.3*§
    Ratio
Hormonesa
Insulin (pmol/L) 182 ± 17 108 ± 3* 160 ± 7 110 ± 4*§ 112 ± 1§ 98 ± 2§
Adiponectin (µg/mL) 9.2 ± 0.4 18.9 ± 3.8* 11.1 ± 1.2 15.3 ± 0.8 8.7 ± 0.3 13.8 ± 1.0
Lipids (mg/dL)a
Triglyceride 31.5 ± 3.2 5.0 ± 0.8* 45.5 ± 0.3§ 7.3 ± 0.2*§ 8.4 ± 2.3§ 7.3 ± 1.0§
Cholesterol 28.3 ± 2.0 15.9 ± 2.8* 45.9 ± 2.6§ 30.3 ± 0.3* 22.8 ± 0.5 26.0 ± 2.8
Free fatty acid 42.7 ± 3.4 64.6 ± 4.5* 48.1 ± 3.5 57.1 ± 2.5*§ 41.2 ± 2.4 44.9 ± 0.9
Cholesteryl Ester 32.1 ± 0.9 26.7 ± 0.5 55.8 ± 0.8§ 41.0 ± 1.4§ 31.9 ± 1.3 34.5 ± 3.4
Phosphatidylcholine 64.2 ± 3.8 42.2 ± 2.1* 107.9 ± 4.9§ 68.8 ± 2.9* 52.7 ± 2.3§ 59.5 ± 4.4
Lyso-phosphatidylcholine 9.3 ± 0.3 5.5 ± 0.5* 10.6 ± 0.3 6.7 ± 0.2 6.6 ± 0.6 5.7 ± 0.7
Phosphatidylethanolamine 4.0 ± 0.5 2.6 ± 0.4* 8.2 ± 0.9§ 5.6 ± 0.1§ 2.2 ± 0.4§ 3.0 ± 0.0
Sphingomyelin 6.8 ± 0.3 3.9 ± 2.0* 10.3 ± 0.9§ 10.2 ± 0.4§ 6.9 ± 0.1 8.2 ± 0.9
§ Indicates significance from unrestricted standard diet at p < 0.01 as determined by one-way ANOVA
a Values are expressed as the mean ± SEM (n = 4 mice per group)
* Indicates significance from unrestricted diet at p  < 0.01 as determined by one-way ANOVA
Table 5.  Influence of dietary intake on plasma metabolites, hormones, and lipids in C57BL/6J mice
Diet
Standard Diet Ketogenic Diet Fish-Oil Diet
!! 72!
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Fat Intake .494* .024
Carbohydrate Intake .004 .496* -.725**
Glucose .922** .707** .601** -.019
Ketone -.610** -.860** .266 -.619** -.478*
Insulin .677** .687** .319 .202 .745** -.495*
Adiponectin -.640** -.523** -.318 .107 -.611** .414* -.282
Triglyceride .863** .653** .568** -.006 .940** -.477* .694** -.579**
Cholesterol .654** .262 .837** -.522** .772** -.005 .536** -.469* .811**
Free Fatty Acids -.194 -.265 .099 -.144 -.168 .175 -.077 .123 -.200 -.142
Cholesteryl Ester .560** .079 .922** -.673** .667** .133 .372 -.396 .704** .944** .009
Phosphatidylcholine .358 .117 .437* -.317 .401 .044 .306 -.400 .480* .674** -.164 .550**
Lyso-phosphatidylcholine .843** .661** .588** -.020 .939** -.437* .772** -.537** .957** .834** -.221 .706** .536**
Phosphatidylethanolamine .555** .122 .880** -.500* .690** .150 .481* -.303 .734** .916** -.083 .903** .666** .755**
Sphingomyelin .250 -.087 .722** -.691** .405 .377 .324 -.209 .370 .814** -.160 .760** .621** .492* .734**
*p < 0.05, two-tailed t-test
**p < 0.01, two-tailed t-test
















Aldrich,!St.!Louis,!MO),!water!plus!25!mM!DCglucose!and!8!mM!2CdeoxyCDCglucose!(2CDG)!(Sigma!Aldrich),!or!water!plus!25!mM!DCglucose!and!50!mM!βChydroxybutyrate!(bOHB)!(Sigma!Aldrich).!!Immediately!before!seizure!testing,!all!water!bottles!were!changed!back!to!water!alone.!!Pretrial!Period!The!pretrial!period!began!when!the!mice!were!40!±!1!days!of!age!and!lasted!for!seven!weeks.!!During!this!time,!all!mice!were!groupChoused!and!fed!ad!libitum.!!They!were!tested!for!seizure!susceptibility!once!per!week.!!Only!mice!that!had!demonstrated!at!least!one!generalized!seizure!during!the!pretrial!period!were!included!in!the!study.!!The!mean!number!of!seizures!that!mice!experienced!before!beginning!the!study!was!2.57!±!0.13!(standard!error!of!the!mean).!!Treatment!Period!! After!the!7Cweek!pretrial!period,!the!mice!were!arranged!into!five!groups!(n!=!13C15!mice/group).!!All!mice!were!then!fasted!for!16!hours!to!establish!a!similar!metabolic!state!at!the!start!of!the!experiment.!!!The!mice!in!each!group!were!assigned!to!one!of!five!dietary!conditions:!1) Standard!diet!(SD)!fed!ad!libitum!with!water!alone!prior!to!seizure!testing!(SDCUR),!2) SD!restricted!to!achieve!a!20C23%!body!weight!reduction!with!water!alone!prior!to!seizure!testing!(SDCR),!
! 79!


































































































































































































































































































































































































































































































Treatment&Group Lactate N'acetylaspartate GABA Glutamate Aspartate Taurine
SD'UR 40.8=±=2.1 57.0=±=6.5 16.6=±=2.2 75.6=±=2.2 18.1=±=1.9 57.9=±=3.9
SD'R 36.6=±=1.4 56.3=±=3.9 12.7=±=0.7 73.1=±=2.9 15.3=±=0.8 56.5=±=3.0
SD'R[Glu] 39.1=±=1.9 55.8=±=1.9 10.9=±=0.7 70.9=±=4.1 13.4=±=1.3 53.1=±=2.8
SD'R[Glu][2DG] 40.5=±=2.6 57.0=±=2.9 10.2=±=1.4 74.8=±=1.8 13.3=±=1.9 53.2=±=2.5













(1) [Glucose(Ketone(Index] = [Glucose)(mg/dL)] !".!"#[Ketone#(mM)] !!(2) [Glucose)(mg/dL)] = [Glucose((mM)](×!18.016!(3) [Glucose)(mM)] = [Glucose((mg/dL)]!".!"# !(4) [Ketone'(mg/dL)] = [Ketone&(mM)]&×!10.41!
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Figure 21. The Glucose Ketone Index Calculator tracking an individual’s GKI with a 
target GKI of 1. The individual glucose and ketone values are displayed, along with the 
corresponding GKI values. The GKI values are plotted over the course of a month in 































Figure 22. The Glucose Ketone Index Calculator tracks an individual entering their 
target metabolic zone of management. After an individual’s Glucose Ketone Index falls 
below their target value, they have entered the metabolic zone of management. Tumor 

























































Figure 23. Effect of Glucose Ketone Index values on mouse brain tumor growth. Mice 
were implanted intracerebrally with syngeneic mouse CT-2A astrocytoma, and were put 
on an ad libitum or a calorie-restricted diet (40% daily calorie restriction) beginning 3 
days after tumor implantation. Mice with lower GKI values had less brain tumor growth 
than mice with high GKI values. Modified with permission from Seyfried, Kiebish, 
Marsh, Shelton, Huysentruyt, & Mukherjee. (2011). Biochimica et Biophysica Acta – 



























15.2 % % % % %%%%3.7%% Glucose%Ketone%Index%
! 125! !
Table&8.&Low&Glucose&Ketone&Index&values&are&correlated&with&improved&prognoses&in&humans&and&mice&with&brain&tumors.
Subjects Tumor&Type Diet Prognosis
Human1 Anaplastic.Astrocytoma KD4URa 1 0 5.5 0.2 27.5 No.response.to.standard.chemotherapy
.(Stage.IV) 56 5.0 4.6 1.1 FDG.uptake.at.tumor.site.was.decreased.by.21.77%;.tumor.margins.were.unchanged
Cerebellar.Astrocytoma. KD4UR 1 0 5.5 0.2 27.5 Tumor.resected.and.initiated.on.KD.while.under.standard.chemotherapy,
.(Grade.III) ..after.tumor.was.radiologically.stable.by.CT
56 4.0 5.5 0.7 FDG.uptake.at.tumor.site.was.decreased.by.21.84%
Notes:.Both.patients.remained.in.remission.after.return.to.standard.diet.for.5.years
.(Subject.1).and.4.years.(Subject.2),.at.time.of.publication
Human2 Glioblastoma. KD4Rb 1 0 7.5 0.2g 37.5 Incomplete.surgical.resection.of.tumor;.received.chemotherapy.and.radiation
.Multiforme.(Grade.IV) .therapy.concurrent.with.diet
21 3.5 2.5g 1.4 No.evidence.of.tumor.by.MRI.after.concurrent.therapy
Notes:.Patient.stayed.on.low.calorie.diet.for.an.additional.5.months;.tumor
.recurrence.3.months.after.low4calorie.diet.suspension
Mouse3 mouse.CT42A.astrocytoma SD4URc 7 13 9.1 0.6 15.2 Tumor.dry.weight:.55.±.15.mgh
.syngenic.(C57BL/6J) SD4Rd 6 13 5.2 1.4 3.7 Tumor.dry.weight:.7.±.7.mg
KD4UR 14 13 11.4 1.0 11.4 Tumor.dry.weight:.70.±.15.mg
KD4R 6 13 5.7 1.3 4.4 Tumor.dry.weight:.14.±.8.mg
Mouse4 mouse.CT42A.astrocytoma SD4UR 12414 8 14.0 0.2 70.0 Tumor.dry.weight:.95.±.25.mgh
.syngenic.(C57BL/6J) KD4UR 12414 8 13.5 0.6 22.5 Tumor.dry.weight:.90.±.15.mg.
KD4R 12414 8 8.0 1.8 4.4 Tumor.dry.weight:.35.±.5.mg
human.U87.glioma SD4UR 12414 8 11.5 0.5 23.0 Tumor.dry.weight:.60.±.10.mgh
.xenograft.(SCID) KD4UR 12414 8 11.5 1.2 9.6 Tumor.dry.weight:.60.±.7.mg
KD4R 12414 8 5.5 3.0 1.8 Tumor.dry.weight:.37.±.5.mg
Mouse5 mouse.GL261.astrocytoma SD4UR 19 13 10.0 0.2 50.0 Median.survival.time:.23.days
.(C57BL/64cBrd/cBrd/Cr) KD4UR 19 13 8.9 1.4 6.4 Median.survival.time:.28.days
SD4UR.+.Rade 11 13 9.7 0.3 32.3 Median.survival.time:.41.days
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